Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for refractory hypoparathyroidism
2013-001890-26Phase 3Active
- Sponsor
- University of Studies
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of teriparatide in hypoparathyroidism, sponsored by University of Studies. Primary endpoint: Reduction in oral calcium and active vitamin D supplementation requirements. Started Mar 2014; status: active.
02
Drugs
teriparatide
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on 2013-001890-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001890-26.